Related Experiment Video
Updated: Apr 1, 2026

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis
Published on: December 15, 2011
Childhood coeliac disease: diagnostic pathways update
European guidelines now allow diagnosing coeliac disease in some symptomatic children without a biopsy. This change aids earlier identification by health professionals, detailing new diagnostic pathways.
Area of Science:
- Paediatric Gastroenterology
- Clinical Diagnostics
- Autoimmune Disorders
Background:
- Coeliac disease diagnosis traditionally requires a small-bowel biopsy.
- European guidelines have been modified regarding coeliac disease diagnosis.
- Early identification of coeliac disease is crucial for managing complications.
Purpose of the Study:
- To inform health professionals about updated European guidelines for coeliac disease diagnosis.
- To detail the revised diagnostic pathways for coeliac disease in children.
- To highlight the possibility of diagnosing coeliac disease without a biopsy in select cases.
Main Methods:
- Review of modified European guidelines for coeliac disease diagnosis.
- Analysis of updated recommendations from Coeliac UK and the British Society of Paediatric Gastroenterology, Hepatology and Nutrition.
- Description of diagnostic criteria for coeliac disease in symptomatic children.
Main Results:
- Coeliac disease can now be diagnosed without a small-bowel biopsy in a specific group of symptomatic children.
- Updated guidance facilitates earlier identification of coeliac disease.
- New diagnostic pathways are established for health professionals to follow.
Conclusions:
- The modification of European guidelines simplifies coeliac disease diagnosis in certain paediatric populations.
- Adoption of new recommendations by professional bodies promotes earlier and potentially less invasive diagnosis.
- Health professionals are equipped with updated information to identify and manage coeliac disease more effectively.
More Related Videos
Related Concept Videos
Serum Laboratory Studies, Stool Test, Breath Test
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Chronic Pancreatitis II: Collaborative Care
Assessment:
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...

